Stoke Therapeutics (STOK) Stock Price
$8.33 0%
to add to portfolio
AI Score
-
Alternative
4 -
Fundamental
3 -
Technical
3
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Stoke Therapeutics, AI stock picks, stock alerts and much more.
STOK AI Stock Analysis
AI stock analysis for STOK is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Stoke Therapeutics (STOK) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Stoke Therapeutics (STOK) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Stoke Therapeutics (STOK), currently trading at $8.33, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About STOK
-
Stoke Therapeutics, Inc.
-
Symbol
STOK
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
441.2M
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$21.62 2% |
6 |
 |
Inovio Pharmaceuticals INO |
$2.24 0.9% |
2 |
 |
Moderna MRNA |
$35.53 5.3% |
4 |
 |
Anavex Life Sciences AVXL |
$8.35 3.8% |
6 |
 |
BridgeBio Pharma BBIO |
$36.85 0.1% |
6 |
News
STOK Alternative Data
Web Traffic
Stoke Therapeutics receives an estimated 7461 monthly visitors to stoketherapeutics.com.
-
Web Traffic
7461
-
Change from Previous Month
24.6%
-
3 Month Change
6.2%
-
YoY Change
6.2%
News Mentions
Stoke Therapeutics was mentioned 1 times in the news yesterday.
-
News Mentions
1
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Reddit Mentions
Stoke Therapeutics has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
Twitter Followers
Stoke Therapeutics has 1,541 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.5% over the last month.
-
Twitter Followers
1541
-
Daily Change
0.1%
-
1 Month Change
0.5%
-
3 Month Change
0.4%
LinkedIn Followers
13,954 are following Stoke Therapeutics on LinkedIn, up by 3.4% over the last month.
-
LinkedIn Followers
13954
-
Daily Change
0.2%
-
1 Month Change
3.4%
-
3 Month Change
8%
Job Postings
Stoke Therapeutics currenly has an estimated 7 open job postings.
-
Job Postings
7
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
16.7%
LinkedIn Employees
According to LinkedIn, Stoke Therapeutics has 139 employees, up by 0.7% over the last month.
-
LinkedIn Employees
139
-
Daily Change
0%
-
1 Month Change
0.7%
-
3 Month Change
3%
Business Outlook
-
Business Outlook
85
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
STOK Financials
STOK Key Metrics
-
Total Revenue
$4.9M
-
Net Income
-$26.4M
-
Earnings per Share
-$0.47
-
Free cash flow
-$21.7M
-
EBITDA
-$30M
-
EBITDA Ratio
-6.13057
-
Total Assets
$293.3M
STOK 2-year Revenue & Income
STOK 2-year Free Cash Flow
STOK Technicals
STOK SMA
STOK RSI
FAQ
What's the current price of Stoke Therapeutics (STOK) Stock?
The price of an Stoke Therapeutics (STOK) share is $8.33.
What's the market cap of Stoke Therapeutics?
The current market cap of Stoke Therapeutics is 441.2M.
Should I buy or sell STOK?
Stoke Therapeutics exhibits several negative alternative data signals, leading us to expect continued underperformance in the coming months. As a result, we maintain a negative outlook on this stock.
Is Stoke Therapeutics a good investment?
Considering the fundamentals, technical analysis, and alternative data insights, it may not be the best time to invest in Stoke Therapeutics stock. There are several bearish signals and market challenges that could negatively impact Stoke Therapeutics' future performance, suggesting that caution should be exercised before making any investment decisions.
Is now a good time to buy Stoke Therapeutics (STOK) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it may not be the best time to buy Stoke Therapeutics stock right now, as the outlook appears bearish.
What are some stocks similar to Stoke Therapeutics (STOK) that investors often compare it to?
Stoke Therapeutics (STOK) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Stoke Therapeutics' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Stoke Therapeutics' stock price to be around $7.69 in 2026. Starting from the current price of $8.33, this represents a 7.6% change in price, indicating a bearish outlook for the stock.
How to buy Stoke Therapeutics (STOK) Stock?
Stoke Therapeutics stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Stoke Therapeutics shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.